<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-102KL8ZI</identifier><date>2009</date><creator>Čufer, Tanja</creator><creator>Humar, Mojca</creator><relation>documents/doc/1/URN_NBN_SI_doc-102KL8ZI_001.pdf</relation><relation>documents/doc/1/URN_NBN_SI_doc-102KL8ZI_001.txt</relation><format format_type="volume">13</format><format format_type="issue">2</format><format format_type="type">article</format><format format_type="extent">str. 106-109, 151</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID">847483</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-102KL8ZI</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">Anemia</subject><subject language_type_id="slv">Anemija</subject><subject language_type_id="eng">Drug therapy</subject><subject language_type_id="eng">Eritropoetin</subject><subject language_type_id="eng">Erythropoietin</subject><subject language_type_id="eng">Neoplasms</subject><subject language_type_id="slv">Novotvorbe</subject><subject language_type_id="eng">tumor</subject><subject language_type_id="slv">Zdravljenje z zdravili</subject><title>Priporočila za uporabo rastnih dejavnikov za eritrocite pri sistemsko zdravljenih bolnikih z rakom</title></Record>